scholarly journals Assessment and management of viral croup in children

Prescriber ◽  
2016 ◽  
Vol 27 (8) ◽  
pp. 32-37 ◽  
Author(s):  
Marie Wright ◽  
Andrew Bush
Keyword(s):  
Viral Croup

scholarly journals Aetiology and epidemiology of viral croup in Glasgow, 1966–72

1974 ◽  
Vol 73 (1) ◽  
pp. 143-150 ◽  
Author(s):  
K. A. Buchan ◽  
Karen W. Marten ◽  
D. H. Kennedy
Keyword(s):  
Retrospective Study ◽  
Influenza A ◽  
Seasonal Distribution ◽  
Late Autumn ◽  
Small Peak ◽  
Causative Agents ◽  
Autumn And Winter ◽  
Viral Croup

SUMMARYA retrospective study of 258 children admitted to Ruchill Hospital, Glasgow, with croup between 1966 and 1972 indicated that the viruses most frequently associated with the syndrome were parainfluenza types 1 and 3 and influenza A. Most cases were admitted in the late autumn and winter months, with a small peak in May and June. This seasonal distribution mirrored the circulation of the main causative agents in the community, parainfluenza 1 being principally associated with the autumn cases, influenza A the winter cases and parainfluenza 3 the summer cases. Two of these ‘croup associated’ viruses showed regular periodicity, parainfluenza 1 occurring biennially in even years and influenza A in most years. The periodicity of parainfluenza 3 is as yet undetermined.

Corticosteroids in the Management of Laryngotracheobronchitis

1980 ◽  
Vol 88 (3) ◽  
pp. 207-210 ◽  
Author(s):  
Donald B. Hawkins
Keyword(s):  
Airway Obstruction ◽  
Faculty Member ◽  
Initial Treatment ◽  
Clinical Evidence ◽  
University Of Southern California ◽  
Clinical Disorder ◽  
Growing Body ◽  
Margin Of Safety ◽  
The University ◽  
Viral Croup

Chairman's Comments: A growing body of clinical evidence obtained in a scientific manner is supporting the efficacy of corticosteroids for initial treatment of viral croup. Donald B. Hawkins, MD, a member of the Committee on Drugs—Otolaryngology and a faculty member of the Department of Otolaryngology at the University of Southern California, review the results of these studies in a scholarly manner. Dr Hawkins traces the development of the clinical experience with corticosteroids and clearly points out the differences between controls and treated patients in the respective studies. The Committee urges readers to review the articles and discuss the conclusions with their pediatric colleagues. The increased margin of safety afforded by the administration of corticosteroids to patients with laryngotracheobronchitis should be of interest to all physicians concerned with lowering the risk of airway obstruction in this common clinical disorder.

scholarly journals Treatment of acute viral croup.

1978 ◽  
Vol 53 (9) ◽  
pp. 704-706 ◽  
Author(s):  
W Lenney ◽  
A D Milner
Keyword(s):  
Viral Croup

Viral croup: Diagnosis and a treatment algorithm

2014 ◽  
Vol 49 (5) ◽  
pp. 421-429 ◽  
Author(s):  
Argyri Petrocheilou ◽  
Kalliopi Tanou ◽  
Efthimia Kalampouka ◽  
Georgia Malakasioti ◽  
Christos Giannios ◽  
...  
Keyword(s):  
Treatment Algorithm ◽  
Viral Croup

Bacterial tracheitis as a complication of viral croup

1983 ◽  
Vol 2 (5) ◽  
pp. 390-391 ◽  
Author(s):  
KATHRYN M. EDWARDS ◽  
M. CATHERINE DUNDON ◽  
WILLIAM A. ALTEMEIER
Keyword(s):  
Bacterial Tracheitis ◽  
Viral Croup

Oral Betamethasone Versus Intramuscular Dexamethasone for the Treatment of Mild to Moderate Viral Croup

2006 ◽  
Vol 22 (8) ◽  
pp. 541-544 ◽  
Author(s):  
Lisa Amir ◽  
Henry Hubermann ◽  
Ayelet Halevi ◽  
Meirav Mor ◽  
Marc Mimouni ◽  
...  
Keyword(s):  
Viral Croup

CYTOKINE RESPONSE IN CHILDREN WITH VIRAL CROUP

2017 ◽  
Author(s):  
Oleksandr B. Nadraha
Keyword(s):  
Cytokine Response ◽  
Viral Croup

Viral Croup

2013 ◽  
pp. 3044-3044
Keyword(s):  
Viral Croup

Use of Dexamethasone in the Outpatient Management of Acute Laryngotracheitis

PEDIATRICS ◽  
1995 ◽  
Vol 96 (2) ◽  
pp. 220-223
Author(s):  
Minh N. Cruz ◽  
Gail Stewart ◽  
Norman Rosenberg
Keyword(s):  
Intramuscular Injection ◽  
Severity Of Illness ◽  
Ordinal Scale ◽  
Secondary Outcome ◽  
Medical Attention ◽  
Outpatient Management ◽  
Moderate Severity ◽  
Single Intramuscular Injection ◽  
Number Of Patients ◽  
Viral Croup

Objective. Recent studies have demonstrated that a single intramuscular injection of dexamethasone (0.6 mg/kg) shortens the duration and severity of illness in hospitalized patients with acute viral laryngotracheitis (croup). Our objective was to determine if dexamethasone has a role in the outpatient management of patients with acute viral croup of moderate severity. Methods. Patients, 6 months to 5 years of age, who came to the emergency department (ED) with acute viral croup, a croup score of at least 2 (range 0 to 17), and a disposition of discharge were randomized in a double-blind fashion to receive a single intramuscular injection of dexamethasone, 0.6 mg/kg, or an equal volume of normal saline before discharge from the ED. Patients were excluded if they had any structural abnormalities, had received any steroids in the preceding 24 hours, or if they required β-agonist therapy, more than one racemic epinephrine treatment, or hospitalization. Patients were followed up by telephone 24 hours and 7 to 10 days after discharge to determine whether additional medical attention was sought for perceived lack of improvement or worsening of symptoms. Secondary outcome included the parents' perception of how the child was doing at 24 hours, based on a 4-point ordinal scale: worse (1), same (2), improved (3), symptoms resolved (4), and the number of days it took for complete recovery. Results. Of the 38 patients comprising the study group, 19 received dexamethasone. The median age was 19 months (range 6 to 66 months), and median pretreatment croup score was 3 (range 2 to 5) for both groups. The number of patients requiring racemic epinephrine was similar in both groups. Five patients sought additional medical attention within 48 hours. Four of the five patients had received placebo (21% of the placebo group) and one had received dexamethasone (5% of the steroid group) (not statistically significant). At the 24-hour telephone follow-up, significantly more patients in the dexamethasone group had a score consistent with improvement compared with placebo (84% vs 42%, P = .003). There was no difference in the number of days for symptoms to completely resolve between the two groups. Conclusion. The use of dexamethasone in the outpatient management of viral croup was associated with a reduction in severity of illness within 24 hours after treatment. Patients with viral croup of moderate severity should be considered as candidates for the use of dexamethasone before discharge from the ED.

Humidification in viral croup: a controlled trial

1984 ◽  
Vol 20 (4) ◽  
pp. 289-291 ◽  
Author(s):  
D. BOURCHIER ◽  
K. P. DAWSON ◽  
D. M. FERGUSSON
Keyword(s):  
Controlled Trial ◽  
Viral Croup
Sign in / Sign up

Export Citation Format

Share Document